Skip to main content
. 2018 Jul 13;8:60. doi: 10.1186/s13550-018-0419-z

Table 2.

Characteristics of lesions

Min Q1 Median Q3 Max
Baseline TLG (g) 10 36 71 165 1228
Baseline SUVpeak (g/ml) 3 5 6 8 13
Follow-up TLG (g) 0 0 7 61 5115
Follow-up SUVpeak (g/ml) 1 3 4 5 14
TLG-decrease (%) − 1116 8 96 100 100
SUVpeak-decrease (%) − 45 11 43 57 91
Lesion mean absorbed dose (Gy) 8 39 55 89 268